Image Ben Hargreaves Oncology Can CAR-T first movers keep pace in a rapidly evolving marke... The CAR-T landscape has quickly transformed from a pioneering breakthrough to a highly competitive and evolving market. R&D Brain-computer interfaces could redefine precision medicine BCIs could emerge as a ground-breaking tool for the pharma industry, offering new ways to understand and treat complex conditions. Market Access Moderna’s missteps spotlight PMCPA’s role in upholding pharm... The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards. Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike Load more results
Oncology Can CAR-T first movers keep pace in a rapidly evolving marke... The CAR-T landscape has quickly transformed from a pioneering breakthrough to a highly competitive and evolving market.
R&D Brain-computer interfaces could redefine precision medicine BCIs could emerge as a ground-breaking tool for the pharma industry, offering new ways to understand and treat complex conditions.
Market Access Moderna’s missteps spotlight PMCPA’s role in upholding pharm... The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards.
Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike
News Ambros' $125m for pain disorder drug, and other financings Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
